Skip to main content

Cofactor Genomics Named Agilent CSP for NGS Target Enrichment

NEW YORK (GenomeWeb) – Cofactor Genomics today said that it has been named a certified service provider for Agilent's SureSelect Methyl-Seq target enrichment.

The St. Louis-based firm said that it has "built one of the most comprehensive methylation analysis services in the industry and is able to handle every piece of the project, from DNA extraction to analysis."

"One of the next logical steps in understanding genetic modulation by modification is to assess the methylation state of DNA," Cofactor Genomics CSO Jon Armstrong said in a statement. "We … look forward to providing ground-breaking results in the study of epigenetics with their products."

Last September Cofactor received a $300,000 grant from the National Heart, Lung, and Blood Institute and the National Human Genome Research Institute to identify sites of epigenetic modifications that contribute to cardiovascular disease endpoints.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.